PGY2 Program Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program Overview

The Johns Hopkins Hospital PGY-2 Thrombosis and Hemostasis Residency is twelve-month training and experience. The residency is currently in candidate status with ASHP with plans to pursue accreditation after graduation of the first resident. The program provides flexibility to meet the interests and needs of the individual resident while at the same time ensuring the achievement of foundational skills for high quality thrombosis and hemostasis pharmacy practice. This residency provides experience to numerous patient populations within thrombosis and hemostasis and strives to produce experts in this area of practice. The residency will emphasize the resident’s interests while achieving the goals and objectives for PGY2 Thrombosis and Hemostasis Residencies set forth by ASHP. Additionally, The Johns Hopkins Hospital is one of four recipients of the Anticoagulation Forum TRAIN Grant for PGY2 Thrombosis and Hemostasis Residents in 2023-2024 and 2024-2025. As part of the TRAIN Grant, the resident and residency program director is required to participate in monthly topic discussions with the other TRAIN Grant sites.

Program Goals

Residents who complete this program will be prepared with the knowledge and clinical skills to become a clinical pharmacy specialist in thrombosis and hemostasis and serve as leaders in anticoagulation stewardship program development and implementation.

Requirements for Acceptance to the Program

The qualified candidate is required to have a Doctor of Pharmacy degree from an ACPE accredited school of pharmacy. Prior to the beginning of a PGY2 residency, PGY2 residents are required to have successfully completed an ASHP-accredited PGY1 pharmacy residency program.

Licensure and Certification Requirements

All residents are required to obtain a Maryland State Pharmacy License by August 1st.

The resident will arrive at the program already ACLS certified, or will complete certification during the residency year.

Orientation

The Pharmacy Residency Orientation experience provides a comprehensive and coordinated training program designed to provide incoming residents with an understanding of policies, procedures, and expectations for the pharmacy residency experience. During orientation, residents will participate in hospital, department, and division orientation, and will be exposed to department policies and resources.

Hospital and pharmacy department orientation is required for all new pharmacist hires at Johns Hopkins Hospital. The resident is expected to interact with members of the pharmacy department throughout orientation and to attend assigned orientation and training sessions.

Prior to the start of the residency program, residents will be given a full, detailed orientation itinerary.

Rotations

Each PGY2 resident will spend two thirds or more of the PGY2 program in direct patient care activities.

Required Rotations

• Orientation (1 calendar month)
  • Includes completion of the ASHP Anticoagulation Certificate Program
• Adult Benign Hematology I (1 calendar month)
• Adult Hemostatic and Antithrombotic Stewardship I (1 calendar month)
• Adult Benign Hematology and Hemostatic/Antithrombotic Stewardship I (1 calendar month)
• Adult Benign Hematology and Hemostatic/Antithrombotic Stewardship II (1 calendar month)
• Cardiac Intensive Care Unit (CCU) I (1 calendar month)
• Cardiovascular Surgical Intensive Care Unit (CVSICU) I (1 calendar month)
• General Cardiology I (1 calendar month)
• Neurosciences Critical Care Unit (NCCU) I (1 calendar month)
• Precepting (assigned during a learning experience with co-precepting opportunities)
• Research (longitudinal, August – June; includes dedicated month for research activities in December)
• Clinical Laboratory Science (longitudinal, August-June)
• Antithrombotic and Hemostatic Agent Adult Medication Safety Event Review (longitudinal, August-June)
• JHH Ambulatory Anticoagulation Management (longitudinal 11 months, includes warfarin clinic 1/2 day every other week August-January, remote INR monitoring for LVAD patient, and perioperative bridging consults August-June)
• JHBMC Ambulatory Anticoagulation Management (longitudinal 5 months, 1/2 day every other week)
  • This learning experience occurs off-site at Johns Hopkins Bayview Medical Center, which is located approximately 3 miles from The Johns Hopkins Hospital
• Adult Hemophilia Clinic (longitudinal 9 months, half-day first Tuesday afternoon of the month)

Elective Rotations

• Adult Benign Hematology II (1 calendar month)
• Cardiac Intensive Care Unit (CCU) II (1 calendar month)
• Other elective learning experiences may be developed based on resident interest and preceptor availability.

Education and Didactic Presentations

• Longitudinal learning experience from August – June
• Pharmacotherapy Rounds
  • All residents are required to provide a 30-minute presentation that is APCE accredited.
  • Please refer to the “Learning Opportunities” section of the Department of Pharmacy, Johns Hopkins Medicine website.
• Journal Clubs and/or Topic Discussions
  • Monthly topic discussions with four other Anticoagulation Forum TRAIN Grant sites
  • Lead biweekly Thrombosis and Hemostasis Management topic discussions
  • Participation in topic discussions for other programs and during learning experiences as appropriate (e.g. cardiology, critical care)
• Teaching Requirements
  • Each Hopkins resident is required to provide continuing education sessions
  • The PGY2 Thrombosis and Hemostasis Resident is required to provide a 1-hour departmental continuing education presentation that is ACPE accredited (in addition to Pharmacotherapy Rounds)
  • A Teaching and Learning Certificate Program is available as an optional learning experience
  • Please refer to the “Learning Opportunities” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Research

This is a longitudinal learning experience spanning from August – June. The resident is required to complete a research or quality improvement project. The scope, magnitude, and type of project will vary according to individual interests but must be completed in a manner suitable for presentation and publication.

Please refer to the “Projects” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Hemostatic and Antithrombotic Stewardship Leadership

The resident will be assigned to departmental, hospital, or health-system committee(s) as a longitudinal learning experience from August – June. The resident is required to serve as the secretary of the Anticoagulation Steering Committee (multidisciplinary, multi-site committee) and Anticoagulation Steering Patient Safety Event Review Subcommittee. The PGY2 Thrombosis and Hemostasis resident is also required to also serve as an active member of the Department of Pharmacy Anticoagulation Committee and Hemostatic and Antithrombotic Stewardship Committee.

The resident is required to complete a drug class review or formulary management project as part of the formulary management process. This may be achieved through assisting in the determination of formulary additions/deletions by assessing therapeutic merits, safety, redundancies, and the estimated cost impact on the JHHS.

Staffing

Each resident will practice as a pharmacist in a designated area throughout the residency year. This is a longitudinal learning experience spanning from August – June.

Please refer to the “Staffing Requirements” section of the Department of Pharmacy, Johns Hopkins Medicine

On-Call Program

The resident will participate in clinical on-call services. This is a longitudinal learning experience spanning from August – June. On-call duties include code response, drug information question responses, pharmacokinetic assessments, administrative assistance, and other duties. On-call hours are from 4 PM to 10 PM on weekdays and 8 AM to 8 PM on weekends and holidays. The frequency of on-call coverage depends upon the number of residents in the entire program and averages about 18 shifts per year.

Please refer to the “On Call Program” section of the Department of Pharmacy, Johns Hopkins Medicine website. 

Attendance at Professional Meetings

The department will support the resident (expense and leave time) to attend one professional conference. Any additional travel that is to be supported by the department is evaluated on a case-by-case basis.

Please refer to the “Meetings and Conferences” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Paid Time Off (PTO)

Please refer to the “Benefits” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Residency Program Director

Katie Dane, PharmD, BCPS
Clinical Pharmacy Specialist, Benign Hematology and Cardiology
Co-Director, Hemostatic and Antithrombotic Stewardship Program
The John Hopkins Hospital
Department of Pharmacy
600 North Wolfe Street, Carnegie 180
Baltimore, MD 21287-6180
Phone: 410-502-6769
Email: [email protected]

Core Residency Preceptors

Katie Dane, PharmD, BCPS
Clinical Pharmacy Specialist, Benign Hematology/Antithrombotic Stewardship and Cardiac Care Unit

Stephanie Davis, PharmD, BCCCP, CNSC
Clinical Pharmacy Specialist, Cardiovascular Surgical Intensive Care and Clinical Nutrition Support

Rosemary Duncan, PharmD, BCPS
Adult Medication Safety Officer, Department of Pharmacy

Salia Farrokh, PharmD, BCCCP, FNCS
Clinical Pharmacy Specialist, Neurocritical Care

Aklil Hiruy, PharmD, BCPS
Clinical Pharmacy Specialist, General Cardiology

John Lindsley, PharmD, BCCCP, BCCP, AACC
Clinical Pharmacy Specialist, Cardiac Care Unit and Benign Hematology/Antithrombotic Stewardship

Peggy Kraus, PharmD
Clinical Pharmacy Specialist, JHH Ambulatory Anticoagulation

Charlie Twilley, PharmD
Clinical Pharmacy Specialist, JHBMC Ambulatory Anticoagulation